Treatment of Streptozotocin-Diabetic Dogs With a Long-Acting Somatostatin Analog
- 1 May 1979
- journal article
- research article
- Published by American Diabetes Association in Diabetes
- Vol. 28 (5), 491-495
- https://doi.org/10.2337/diab.28.5.491
Abstract
A long-acting somatostatin analog, Wy-41,747, improved glucose homeostasis in steptozotocin-diabetic dogs. In insulin-withdrawn, fasted dogs, a single 100 μg/kg s.c. injection of Wy-41,747 significantly suppressed plasma glucagon levels for 2 h (a nadir of 53 ± 8% of basal being reached at 1 h) and plasma glucose for 3 h (77 ± 5% of basal); even more potent suppression of glucagon and glucose levels was observed during experiments with 500 μ/kg of Wy-41,747. During meal studies, the combined administration of Wy-41,747 (100 μ/kg) and insulin resulted in lower postprandial glucagon and glucose levels than did the administration of insulin alone. When the somatostatin analog was given alone to fed animals, a rise in glucose occurred 4-5 h after the meal, suggesting the possibility of delayed absorption under these conditions. Improved glucose tolerance profiles followed oral administration of glucose or 14C-3-O-methyl glucose; a normal or near-normal time course of absorption was observed with diminished peak plasma glucose or 14C levels. No major malabsorption of carbohydrate occurred in the 14C-3-O-methyl glucose study, since only low levels of 14C were found in the feces of peptide-treated dogs. No undesirable gastrointestinal effects were noted during these studies. In conclusion, administration of a singlesubcutaneous dose of the long-acting somatostatin analog Wy-41,747 to streptozotocin-diabetic dogs lowered fasting plasma glucose levels and augmented insulin action in lowering postprandial glucose levels.This publication has 12 references indexed in Scilit:
- Inhibition by Somatostatin of Glucagon-Induced Glucose Release from the Isolated Perfused Rat LiverEndocrinology, 1977
- The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetesDiabetologia, 1977
- The Roles of Insulin and Glucagon in the Regulation of Gluconeogenesis in the Postabsorptive DogDiabetes, 1977
- Clinical evaluation of somatostatin as a potential adjunct to insulin in the management of diabetes mellitusDiabetologia, 1977
- Prolonged suppression of pituitary and pancreatic hormone release by a somatostatin analogBiochemical and Biophysical Research Communications, 1977
- Somatostatin: Analogs with Selected Biological ActivitiesScience, 1977
- THE HYPOGLYCAEMIC ACTION OF SOMATOSTATIN IN THE ANAESTHETIZED DOGClinical Endocrinology, 1977
- The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.JCI Insight, 1976
- A novel cyclic undecapeptide, Wy-40,770, with prolonged growth hormone release inhibiting activityBiochemical and Biophysical Research Communications, 1976
- The Banting Memorial Lecture 1975: Diabetes and the Alpha CellDiabetes, 1976